Introduction
Materials and methods
Patients and clinical examination
ELISA
Statistical analyses
Results
Characteristics | Recent-onset RA (n= 43) | Healthy controls (n= 32) |
---|---|---|
Gender, F/M | 30/13 | 11/21 |
Mean age, years (±SD) | 50.90 ± 16.40 | 43.97 ± 15.4 |
Mean CRP, mg/L (±SD) | 16.20 ± 20 | |
Mean ESR, mm/1st hour (±SD) | 34.20 ± 23.72 | |
Mean SJC out of 66 (±SD) | 10.00 ± 9.28 | |
Mean DAS28 score (±SD) | 5.31 ± 1.51 | |
RF positivity, n (%) | 32 (74.4%) | |
Anti-CCP positivity, n (%) | 22 (51.2%) | |
DMARDs/GCs, number of patients | 42/35 |
S100 proteins and disease activity at baseline
Effect of conventional treatment on the levels of S100 proteins
Predictive role of S100 proteins
Initial DAS28 (n= 43; r2 = 0.422; F= 16.355; P< 0.000)b | ΔDAS28 (n= 41; r2 = 0.349, F= 11.727; P< 0.000)c | ||||||||
---|---|---|---|---|---|---|---|---|---|
Variables | Parameter estimate | SEM | t-value | Pvalue | Variable | Parameter estimate | SEM | t-value |
P value
|
Intercept | 4.351 | 0.246 | 17.662 | 0.000 | Intercept | -2.117 | 0.277 | -7.649 | 0.000 |
Initial CRP | 0.037 | 0.010 | 3.619 | 0.001 | Initial CRP | 0.080 | 0.038 | 2.124 | 0.040 |
Initial S100A8/9 | 0.000 | 0.000 | 2.007 | 0.052 | ΔCRP | 0.136 | 0.042 | 3.248 | 0.002 |
Initial SJCs (n= 43, r2 = 0.260, F= 8.360; P= 0.001)b | ΔSJCs (n= 41, r2 = 0.245, F= 13.974; P= 0.001)c | ||||||||
---|---|---|---|---|---|---|---|---|---|
Variables | Parameter estimate | SEM | t-value | Pvalue | Variable | Parameter estimate | SEM | t-value | Pvalue |
Intercept | 5.093 | 1.712 | 2.975 | 0.005 | Intercept | -5.192 | 1.148 | -3.500 | 0.001 |
Initial CRP | 0.147 | 0.071 | 2.067 | 0.045 | ΔS100A8/9 | 0.001 | 0.000 | 3.738 | 0.001 |
Initial S100A8/9 | 0.001 | 0.000 | 2.010 | 0.051 | - | - | - | - | - |